Category
Pharmaceuticals
-
•
GAO evaluates FDA’s overseas inspectors
A couple of new GAO reports are seeking to shed some light on the FDA’s overseas regulatory efforts. The first…
-
•
Seniors more vulnerable to painkillers’ risks
Mary Shedden, of The Tampa Tribune, delves into the dangers of prescription medicines in older people, whose bodies may be…
-
ProPublica investigates pharma payments to doctors
ProPublica’s massive investigation into the hefty fees pharmaceutical companies have paid doctors with dubious track records stamps an exclamation point…
-
•
Who monitors pharmacies’ systems to curb pseudoephedrine sales?
CVS Pharmacy has been in the news recently after it agreed to pay $75 million in penalties and forfeit $2.6…
-
•
Did PLoS suffer from COI in ghostwriting article?
Remember that examination of Wyeth (now Pfizer)’s ghostwriting practices that ran in PLoS Medicine a few weeks back? Well, Pharmalot’s…
-
•
Florida pill mills spread, resist prosecution
With South Florida beginning to crack down, the pain pill mills that fuel the Appalachian drug trade are moving northward.…
-
•
Everyone reacts to Avandia roller coaster
First, the background: Avandia, also known as rosiglitazone, is an anti-diabetes drug that helps patients control their blood sugar. It…
-
•
Pharmaceutical spending varies geographically
The New England Journal of Medicine has examined geographical variation in Medicare drug spending, an area the authors said previous…
-
•
Ethics professor takes on clinical trials, marketing
Writing for Mother Jones, University of Minnesota medical ethics professor Carl Elliott digs into the Dan Markingson story first covered…
-
•
Pfizer-funded workshop raises questions of ethics
Christopher Weaver, in a piece from Kaiser Health News and NPR, writes about a Pfizer-funded seminar for journalists. To attend…